Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer.

While +LN count and LND independently predict OM, the impact of LND is negligible in men with ≤3 +LN, who comprise the vast majority of men with +LN. Pathological nodal staging should primarily rely on LN count rather than LND.